NASDAQ

Rocket Pharmaceuticals, Inc. (RCKT)

♥ 489 Thanks from members

Live price chart, market sentiment, and community perspectives for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Dmitri BellFounder: Bishnu JoshiLeadership: Gaurav Shah (CEO)Leadership: Jonathan Schwartz (CFO)Holder: RA Capital ManagementHolder: Fidelity Management and ResearchHolder: BlackRock, Inc.RP-L101 for Fanconi AnemiaRP-A501 for Danon DiseaseRP-L302 for Pyruvate Kinase Deficiency#RCKT#Rocket Pharmaceuticals#Gene Therapy#Biotech Stock#Rare Diseases